REMICADE
Showing 1 - 25 of 241
IBD, Ulcerative Colitis, Crohn Disease Trial in Boston (Vitamin D3)
Recruiting
- IBD
- +2 more
- Vitamin D3
-
Boston, Massachusetts
- +1 more
Aug 4, 2022
Rheumatoid Arthritis Trial in Shanghai (Infliximab)
Completed
- Rheumatoid Arthritis
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 8, 2021
Sterile Corneal Melt Trial in Montreal (Topical Infliximab)
Recruiting
- Sterile Corneal Melt
- Topical Infliximab
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Dec 12, 2022
Ulcerative Colitis Trial in Melbourne (Infliximab)
Active, not recruiting
- Ulcerative Colitis
-
Melbourne, Victoria, AustraliaAustin Health
Jun 19, 2022
Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)
Enrolling by invitation
- Aneurysm
- +3 more
-
San Francisco, CaliforniaUCSF Medical Center
Apr 25, 2022
Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated
Completed
- Covid19
- +2 more
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Glaucoma Following Surgery Trial in Montréal (Topical infliximab, No topical infliximab)
Recruiting
- Glaucoma Following Surgery
- Topical infliximab
- No topical infliximab
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Jul 4, 2022
Multisystem Inflammatory Syndrome-Children Trial in San Diego, Detroit (Infliximab, Anakinra, Methylprednisolone)
Recruiting
- Multisystem Inflammatory Syndrome-Children
- Infliximab
- +2 more
-
San Diego, California
- +1 more
Mar 28, 2022
Metastatic Melanoma Trial in Boston (Pembrolizumab, Infliximab, Placebo)
Recruiting
- Metastatic Melanoma
- Pembrolizumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Apr 6, 2022
Switch From Original Infliximab to Its Biosimilar in Daily
Completed
- Rheumatoid Arthritis
- +3 more
- Switch from REMICADE® to INFLECTRA®
-
Paris, FranceHôpital Cochin
Apr 30, 2021
Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)
Active, not recruiting
- Colitis,Ulcerative
- Discontinuation of anti-TNF treatment
- Continuation of anti-TNF treatment
-
Alesund, Norway
- +18 more
Jul 13, 2022
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy, Retinal Detachment Trial in Cairo (Intravitreal infliximab,
Recruiting
- Rhegmatogenous Retinal Detachment
- +2 more
- Intravitreal infliximab
- Pars plana vitrectomy
-
Cairo, EgyptCairo University
Nov 26, 2021
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022
Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)
Completed
- Kidney Transplant
- Infliximab
- +9 more
-
Birmingham, Alabama
- +14 more
Jul 19, 2022
Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.
Recruiting
- Rheumatoid Arthritis
- +2 more
- Infliximab: Adalimumab; Etanercept;
-
Sulaymaniyah, Kurdistan Region, IraqHiwa Khidhir Saaed
May 12, 2022
Post-Operative Crohn's Disease Outcome in Children
Recruiting
- Crohn Disease
- Azathioprine
- Anti-TNF Drug
-
Petach Tikva, IsraelSchneider Children's Hospital
Sep 25, 2021
Precision Crohn's Disease Management Utilizing Predictive
Active, not recruiting
- Crohn's Disease
- IBD
-
Hartford, Connecticut
- +3 more
Feb 10, 2022
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Real-World Emulation of the SWEFOT Trial
Completed
- Rheumatoid Arthritis
- Infliximab
- Sulfasalazine + Hydroxychloroquine
-
Stockholm, SwedenKarolinska Institutet, Department of Medicine Solna, Clinical Ep
Sep 22, 2021